Next Viable Routes to Targeting Pancreatic Cancer Stemness: Learning from Clinical Setbacks

Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignancy. Existing therapeutic strategies only provide a small survival benefit in patients with PDAC. Laboratory and clinical research have identified various populations of stem-cell-like cancer cells or cancer stem c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Kelvin K., Chan, Tze-Sian, Shaked, Yuval
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571629/
https://www.ncbi.nlm.nih.gov/pubmed/31108941
http://dx.doi.org/10.3390/jcm8050702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571629/
https://www.ncbi.nlm.nih.gov/pubmed/31108941
http://dx.doi.org/10.3390/jcm8050702

Ejemplares similares